Molecular Minimal Residual Disease in Acute Myeloid Leukemia
- PMID: 29926700
- DOI: 10.1056/NEJMc1805501
Molecular Minimal Residual Disease in Acute Myeloid Leukemia
Comment in
-
Molecular Minimal Residual Disease in Acute Myeloid Leukemia.N Engl J Med. 2018 Jun 21;378(25):2443. doi: 10.1056/NEJMc1805501. N Engl J Med. 2018. PMID: 29924951 No abstract available.
Comment on
-
Molecular Minimal Residual Disease in Acute Myeloid Leukemia.N Engl J Med. 2018 Mar 29;378(13):1189-1199. doi: 10.1056/NEJMoa1716863. N Engl J Med. 2018. PMID: 29601269
Similar articles
-
How Do We Use Multicolor Flow Cytometry to Detect Minimal Residual Disease in Acute Myeloid Leukemia?Clin Lab Med. 2017 Dec;37(4):787-802. doi: 10.1016/j.cll.2017.07.004. Epub 2017 Sep 28. Clin Lab Med. 2017. PMID: 29128069 Review.
-
Molecular Minimal Residual Disease in Acute Myeloid Leukemia.N Engl J Med. 2018 Jun 21;378(25):2442. doi: 10.1056/NEJMc1805501. N Engl J Med. 2018. PMID: 29926698 No abstract available.
-
Molecular Minimal Residual Disease in Acute Myeloid Leukemia.N Engl J Med. 2018 Jun 21;378(25):2443. doi: 10.1056/NEJMc1805501. N Engl J Med. 2018. PMID: 29924951 No abstract available.
-
Monitoring of minimal residual disease in acute myeloid leukemia: methods and best applications.Clin Lymphoma Myeloma Leuk. 2011 Jun;11 Suppl 1:S49-53. doi: 10.1016/j.clml.2011.03.023. Epub 2011 May 1. Clin Lymphoma Myeloma Leuk. 2011. PMID: 22035748 Review.
-
Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis.Clin Lab Med. 2017 Dec;37(4):753-769. doi: 10.1016/j.cll.2017.07.003. Epub 2017 Aug 31. Clin Lab Med. 2017. PMID: 29128067 Review.
Cited by
-
Effectiveness of chemotherapy using bortezomib combined with homoharringtonine and cytarabine in refractory or relapsed acute myeloid leukemia: a phase II, multicenter, prospective clinical trial.Front Oncol. 2023 Aug 18;13:1142449. doi: 10.3389/fonc.2023.1142449. eCollection 2023. Front Oncol. 2023. PMID: 37664023 Free PMC article.
-
Therapeutic hurdles in acute myeloid leukemia: Leukemic stem cells, inflammation and immune dysfunction.Curr Opin Pharmacol. 2025 Jun;82:102526. doi: 10.1016/j.coph.2025.102526. Epub 2025 Apr 8. Curr Opin Pharmacol. 2025. PMID: 40318269 Free PMC article. Review.
-
Single-center experience of venetoclax combined with azacitidine in young patients with newly diagnosed acute myeloid leukemia.Ther Adv Hematol. 2025 Jan 6;16:20406207241311776. doi: 10.1177/20406207241311776. eCollection 2025. Ther Adv Hematol. 2025. PMID: 39777217 Free PMC article.
-
Novel Treatment Paradigms in Acute Myeloid Leukemia.Clin Pharmacol Ther. 2020 Sep;108(3):506-514. doi: 10.1002/cpt.1962. Epub 2020 Aug 11. Clin Pharmacol Ther. 2020. PMID: 32572947 Free PMC article. Review.
-
Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis.J Transl Med. 2023 Feb 11;21(1):115. doi: 10.1186/s12967-023-03968-0. J Transl Med. 2023. PMID: 36774517 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical